Uta Bertsch
Impact in
- Hematology top 0.2%
- Multiple Myeloma Research and Treatments
- Oncology top 2%
- Peptidase Inhibition and Analysis
- Cancer Treatment and Pharmacology
Papers in
- Hematology 87
- Multiple Myeloma Research and Treatments 87
- Oncology 37
- Peptidase Inhibition and Analysis 19
- Cancer Treatment and Pharmacology 17
- Co-authors
- Hartmut Goldschmidt (41 shared papers)Dirk Hose (25 shared papers)Anna Sophia Jauch (15 shared papers)Bronno van der Holt (6 shared papers)Anja Seckinger (19 shared papers)Mark van Duin (5 shared papers)Pieter Sonneveld (6 shared papers)Henk M. Lokhorst (6 shared papers)
- Journals
- Blood (27 papers)Leukemia (10 papers)Blood Cancer Journal (8 papers)Haematologica (6 papers)Journal of Clinical Oncology (4 papers)
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Uta Bertsch
86 papers receiving 4.3k citations
Uta Bertsch's Hit Papers
Peers
Comparison fields: 5 of 83
- Hematology 3.6k
- Oncology 1.7k
- Molecular Biology 2.6k
- Genetics 281
- Pathology and Forensic Medicine 206
Countries citing papers authored by Uta Bertsch
This map shows the geographic impact of Uta Bertsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uta Bertsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uta Bertsch more than expected).
Fields of papers citing papers by Uta Bertsch
This network shows the impact of papers produced by Uta Bertsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uta Bertsch. The network helps show where Uta Bertsch may publish in the future.
Co-authors
The 25 scholars most cited alongside Uta Bertsch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 90 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Bortezomib Induction and Maintenance Treatment in Patients With Newly Diagnosed Multiple Myeloma: Results of the Randomized Phase III HOVON-65/ GMMG-HD4 Trial Hit paper breakdown → | 2012 | 689 |
| 2 | 2011 | 308 | |
| 3 | Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project Hit paper breakdown → | 2022 | 298 |
| 4 | 2010 | 261 | |
| 5 | 2010 | 194 | |
| 6 | 2017 | 162 | |
| 7 | 2010 | 151 | |
| 8 | 2016 | 149 | |
| 9 | 2009 | 137 | |
| 10 | 2022 | 126 | |
| 11 | 2007 | 125 | |
| 12 | 2009 | 116 | |
| 13 | 2012 | 114 | |
| 14 | 2015 | 113 | |
| 15 | 2013 | 102 | |
| 16 | 2018 | 97 | |
| 17 | 2009 | 89 | |
| 18 | 2021 | 77 | |
| 19 | 2010 | 75 | |
| 20 | 2009 | 68 |
About Uta Bertsch
Uta Bertsch is a scholar working on Hematology, Oncology, Molecular Biology, Cancer Research and Pathology and Forensic Medicine, having authored 90 papers that have together received 4.4k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (87 papers), Protein Degradation and Inhibitors (41 papers), Peptidase Inhibition and Analysis (19 papers), Cancer Treatment and Pharmacology (17 papers), Ubiquitin and proteasome pathways (12 papers), Glycosylation and Glycoproteins Research (5 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). The work is most often cited by research in Hematology (3.6k citations), Oncology (1.7k citations), Molecular Biology (2.6k citations), Genetics (281 citations) and Pathology and Forensic Medicine (206 citations). Uta Bertsch has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Hartmut Goldschmidt, Dirk Hose, Anna Sophia Jauch, Bronno van der Holt, Anja Seckinger, Mark van Duin, Pieter Sonneveld, Henk M. Lokhorst, Annemiek Broyl and Laila el Jarari. Their work appears in journals such as Blood, Leukemia, Blood Cancer Journal, Haematologica and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.